Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

77.4K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
77.4K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

1.9K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elderly man with pneumonia.

Journal of the American College of Emergency Physicians open·2021
Same author

Use of Ultrasound in Introducing Anatomical Pathology to Preclinical Medical Students, in Correlation with Physical Exam Curricula.

MedEdPORTAL : the journal of teaching and learning resources·2020
Same author

Man With Blurred Vision.

Annals of emergency medicine·2019
Same author

Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury.

Journal of cellular and molecular medicine·2019
Same author

MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.

BioMed research international·2017
Same author

Learning fiberoptic intubation on a simple model transfers to the O.R.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2016
Same journal

Sarcoma in patients with systemic lupus erythematosus. A systematic review.

Reumatologia·2026
Same journal

Late-onset systemic sclerosis: current concepts, uncertainties, and future practice guidelines.

Reumatologia·2026
Same journal

Clinical and laboratory differences in characteristics of patients with early-onset and late-onset systemic lupus erythematosus: a single-center retrospective study.

Reumatologia·2026
Same journal

A multicentre study for clinical phenotype prediction in juvenile dermatomyositis: categorical principal component analysis-based hierarchical clustering.

Reumatologia·2026
Same journal

Seronegative polymyalgia rheumatica: an update.

Reumatologia·2026
Same journal

Effect of dry needling therapy on hip range of motion as a component of functional performance in patients with chronic low back pain: a randomized clinical trial.

Reumatologia·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.6K

Intestinal microbiota transplant - current state of knowledge.

Jarosław Jerzy Leszczyszyn1, Marek Radomski2, Anna Maria Leszczyszyn3

  • 1National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland; Biotransplant Research, Wroclaw, Poland.

Reumatologia
|July 14, 2016
PubMed
Summary
This summary is machine-generated.

Faecal microbiota transplantation (FMT) shows promise for treating C. difficile colitis and other diseases linked to microbiome changes. More controlled clinical trials are needed to confirm FMT

Keywords:
faecal microbiota transplantationinflammatory bowel diseasemicrobiome

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.6K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.8K

Area of Science:

  • Microbiology
  • Gastroenterology
  • Immunology

Background:

  • Faecal microbiota transplantation (FMT) is gaining attention for its therapeutic potential.
  • FMT is an approved treatment for recurrent Clostridium difficile colitis.
  • Advanced DNA methods reveal microbiome's role in health and disease.

Purpose of the Study:

  • To review the current understanding of the human microbiome.
  • To explore the link between microbiome disturbances and various diseases.
  • To highlight the need for further clinical trials on FMT.

Main Methods:

  • Utilizing sophisticated molecular DNA identification techniques.
  • Assessing human microbiome diversity, variability, and richness.
  • Analyzing metabolic and immunologic functions of the microbiome.

Main Results:

  • Microbiome alterations are associated with inflammatory bowel diseases, irritable bowel syndrome, type 2 diabetes, and rheumatoid arthritis.
  • Pathological changes include altered short-chain fatty acid production and inflammatory cascade components.
  • Published clinical results for FMT are encouraging.

Conclusions:

  • The metabolic and immunologic functions of the microbiome are increasingly understood.
  • FMT holds promise beyond C. difficile colitis.
  • There is a significant need for more controlled FMT clinical trials.